Lowering of Blood Glucose Levels with the Peptide Mixture Deglusterol in In Vitro and In Vivo Models

This study aimed to investigate the blood glucose-lowering effect of the peptide complex Deglusterol, which was isolated from corn extract, in insulin-resistance models. It was found to inhibit insulin receptor substrate (IRS) Ser302 phosphorylation, known as the insulin resistance mechanism, through the inhibition of tumor necrosis factor-α (TNF-α) signaling and the induction of AMP-activated protein kinase phosphorylation. Furthermore, the phosphorylation of IRS Tyr632, phosphoinositide 3-kinase (PI3K), and AKT that is involved in the insulin action mechanism was decreased by TNF-α, whereas Deglusterol increased their phosphorylations, leading to an increase of glucose uptake rate by 190% through glucose transporter type 4 (GLUT4) compared with TNF-α-treated group in C2C12 cells. In addition to insulin signaling activation, Deglusterol treatment resulted in significantly greater mRNA expressions of IRS (190%) and GLUT4 (140%) as well as that of leptin (260%) and adiponectin (140%), which are indicators of insulin sensitivity. In animal models with type 2 diabetes, the blood glucose concentrations in the Deglusterol-administered group were significantly reduced by 50% compared with the control group. Deglusterol suppressed insulin resistance and restored insulin sensitivity, which contributed to lowering blood glucose concentrations in the insulin-resistant models, suggesting its potential as a blood glucose-lowering agent for people at high risk of type 2 diabetes or prediabetes.

• Publication year

  2022

• Venue

  Journal of Medicinal Food

• Publication date

  2022-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jmf.2021.K.0159PMID 35148196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

  2020cited by this paper
• Evaluation of Anti-Diabetic Potential of Corn Silk in High-Fat Diet/Streptozotocin- Induced Type 2 Diabetes Mice Model.

  2020cited by this paper
• The Effect of Corn Silk Ethanol Extract (Zea Mays. L) on Decreasing the Blood Glucose Levels

  2020cited by this paper
• Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets.

  2019cited by this paper
• Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus

  2018cited by this paper
• Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study

  2018cited by this paper
• Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

  2016cited by this paper
• TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice

  2016cited by this paper
• Anti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice

  2015cited by this paper
• Glycaemic Responses to Corn Meals in Type 2 Diabetics and Non-Diabetic Controls

  2015cited by this paper
• Diabetes mellitus and medicinal plants-a review

  2014cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2013cited by this paper
• HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.

  2011cited by this paper
• Anti-diabetic and anti-cholesterolemic activity of methanol extracts of three species of Amaranthus.

  2011cited by this paper
• Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes

  2010cited by this paper
• The effects of corn silk on glycaemic metabolism

  2009cited by this paper
• Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark

  2008cited by this paper
• Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes

  2007cited by this paper
• The role of TNF-alpha in insulin resistance.

  2004cited by this paper
• Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies

  1997cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• The pernicious panacea: herbal medicine.

  1982cited by this paper

• No citing papers are available for this paper.